Knight Jeff E.

ALX Oncology Holdings Inc. ยท Chief Dev & Operating Officer

Knight Jeff E. is listed in public filings as officer: Chief Dev & Operating Officer. This Knight Jeff E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ALX Oncology Holdings Inc. (ALXO), and Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). Investors use Knight Jeff E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ALX Oncology Holdings Inc.ALXO$1.3M800k sharesGrant / ExerciseApr 16, 2026$1.3M800k shares$1.68--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.2M105.3k sharesSellApr 8, 2026$3.4M85.2k shares$40.10--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$1.5M63k sharesGrant / ExerciseApr 8, 2026$1.2M49.5k shares$23.98--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$1.3M66k sharesGrant / ExerciseApr 8, 2026$379.8K19.3k shares$19.64--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$212k10.6k sharesGrant / ExerciseApr 8, 2026$192.7K9.6k shares$20.02--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.3M116k sharesSellMar 16, 2026$220.8K6k shares$37.11--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.2M112k sharesSellMar 16, 2026$149.6K4k shares$37.77--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.4M55k sharesGrant / ExerciseFeb 23, 2026$2.4M55k shares$43.79--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--121.9k sharesGrant / ExerciseFeb 23, 2026Disclosure amount unavailable34k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.0M87.9k sharesSellMar 19, 2025$232.4K6.8k shares$34.17--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.0M87.5k sharesSellMar 19, 2025$12.6K361 shares$34.83--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.4M65k sharesGrant / ExerciseFeb 20, 2025$2.4M65k shares$36.86--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--94.7k sharesGrant / ExerciseFeb 20, 2025Disclosure amount unavailable43k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.9M51.7k sharesSellNov 22, 2024$28.3K501 shares$56.52--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.8M51.7k sharesSellJul 15, 2024$1.5M27k shares$55.00--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$1.7M70.1k sharesGrant / ExerciseJul 15, 2024$419.6K17.5k shares$23.98--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$1.5M78.7k sharesGrant / ExerciseJul 15, 2024$111.7K5.7k shares$19.64--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$405k20.2k sharesGrant / ExerciseJul 15, 2024$57.8K2.9k shares$20.02--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.3M52.6k sharesSellJun 26, 2024$42.4K956 shares$44.38--